Jesús Tercedor-Sánchez (Jesús Tercedor-Sanchez)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Patient Reported

Atopic Dermatitis

Top Venues

Journal of clinical medicine

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Membrive-Jiménez, Sayleth Vieira-Maroun, Noelia Márquez-Pete, Yasmin Cura, Cristina Pérez-Ramírez, Jesús Tercedor-Sánchez, Alberto Jiménez-Morales, María Del Carmen Ramírez Tortosa
ABCC1 , ABCG2 and FOXP3 : Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis. Biomedicines 11 (9) (2023)
Trinidad Montero-Vílchez, Carlos Cuenca-Barrales, Juan-Angel Rodriguez-Pozo, Pablo Diaz-Calvillo, Jesús Tercedor-Sánchez, Antonio Martinez-Lopez, Molina-Leyva Alejandro, Salvador Arias-Santiago
Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of Age. Life (Basel, Switzerland) 12 (1) (2022)
Trinidad Montero-Vílchez, Juan-Angel Rodriguez-Pozo, Pablo Díaz-Calvillo, Maria Salazar-Nievas, Jesús Tercedor-Sánchez, Molina-Leyva Alejandro, Salvador Arias-Santiago
Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study. Journal of clinical medicine 11 (12) (2022)
Manuel Sánchez-Díaz, David López-Delgado, Trinidad Montero-Vílchez, Luis Salvador-Rodríguez, Molina-Leyva Alejandro, Jesús Tercedor-Sánchez, Salvador Arias-Santiago
Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects. Journal of clinical medicine 10 (18) (2021)
Eva Cabrera-Borrego, Trinidad Montero-Vilchez, Francisco José Bermúdez-Jiménez, Jesús Tercedor-Sánchez, Luis Tercedor-Sánchez, Manuel Sánchez-Díaz, Rosa Macías-Ruiz, María Molina-Jiménez, Francisco Javier Cañizares-García, Eduardo Fernández-Segura, Angel Fernandez-Flores, Salvador Arias-Santiago, Juan Jiménez-Jáimez
Heterozygous Arrhythmogenic Cardiomyopathy-desmoplakin Mutation Carriers Exhibit a Subclinical Cutaneous Phenotype with Cell Membrane Disruption and Lack of Intercellular Adhesion. Journal of clinical medicine 10 (19) (2021)